Taylor Wealth Management Partners Amgen Inc Transaction History

Taylor Wealth Management Partners

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 26, 2021	SELL	$212.27 - $248.7 $182,976 - $214,379	-862 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$233.58 - $259.14 $201,345 - $223,378	862 New	862 $210,000
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $11,756 - $13,252	-65 Closed	0 $0
Q3 2017 Oct 13, 2017	BUY	$167.29 - $191.0 $10,873 - $12,415	65	65 $12,000

2,933

401M

6.59M

6.6M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Taylor Wealth Management Partners, based on Form 13F filings with the SEC.

Stay updated on Taylor Wealth Management Partners with notifications on news.